Outcomes of carbon ion radiotherapy and photon stereotactic body radiotherapy using Cyberknife for uveal melanoma
Not Applicable
Recruiting
- Conditions
- uveal melanoma
- Registration Number
- JPRN-UMIN000053540
- Lead Sponsor
- ational Institute for Quantum Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 380
Inclusion Criteria
Not provided
Exclusion Criteria
(i) Cases in which the research subject or his/her representative refuses the use of clinical data for this study. (ii) Recurrent cases, metastatic cases, cases with a history of irradiation to the head and neck region, and cases in which the comorbid invasive cancer has not remained disease-free for at least 3 years (excluding malignant tumors that do not significantly affect prognosis, such as thyroid cancer, MALT lymphoma, basal cell carcinoma of the skin, and early stage prostate cancer). (iii) Patients who are lost to follow-up without at least one post-treatment follow-up visit.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method ocal control rate, adverse events, recurrence-free survival, eye preservation rate